Moolec Science SA Ordinary Shares Total Liabilities
Moolec Science SA Ordinary Shares total liabilities. Based on the latest financial reports, Moolec Science SA Ordinary Shares (MLEC) has total liabilities worth $88.21 Million USD as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check Moolec Science SA Ordinary Shares (MLEC) liquid assets ratio to evaluate the company's liquid asset resilience ratio.
Total Liabilities of Moolec Science SA Ordinary Shares (2021–2025)
Total liabilities of Moolec Science SA Ordinary Shares from 2021 to 2025. This chart illustrates how Moolec Science SA Ordinary Shares's total liabilities have evolved over time, based on quarterly financial data. Explore how much of Moolec Science SA Ordinary Shares's assets are long-term investments to see how much of total assets are deployed in long-term investments.
Moolec Science SA Ordinary Shares Competitors by Total Liabilities
The table below lists competitors of Moolec Science SA Ordinary Shares ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Town Centre Securities PLC
LSE:TOWN
|
UK | GBX188.89 Million |
|
Pond Technologies Holdings Inc
V:POND
|
Canada | CA$11.12 Million |
|
Kuchai Develop Bhd
KLSE:2186
|
Malaysia | RM1.73 Million |
|
DBT SA
PA:ALDBT
|
France | €22.79 Million |
|
FRNT Financial Inc
V:FRNT
|
Canada | CA$476.38K |
|
Sangrix Inc.
NASDAQ:SGRX
|
USA | $14.72 Million |
|
Ivory Properties Group Bhd
KLSE:5175
|
Malaysia | RM206.09 Million |
|
IO Biotech Inc
NASDAQ:IOBT
|
USA | $39.05 Million |
Liability Composition Analysis (2021–2025)
This chart breaks down Moolec Science SA Ordinary Shares's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see balance sheet size of Moolec Science SA Ordinary Shares.
Liquidity & Leverage Metrics
Moolec Science SA Ordinary Shares Total Liabilities Ratios Explained
Moolec Science SA Ordinary Shares total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.15 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 9.57 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.85 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Moolec Science SA Ordinary Shares's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Moolec Science SA Ordinary Shares (2021–2025)
The table below shows the annual total liabilities of Moolec Science SA Ordinary Shares from 2021 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-06-30 | $287.58 Million | +928.14% |
| 2024-06-30 | $27.97 Million | +100.58% |
| 2023-06-30 | $13.95 Million | +241.18% |
| 2022-06-30 | $4.09 Million | -9.31% |
| 2021-06-30 | $4.51 Million | -- |
About Moolec Science SA Ordinary Shares
Moolec Science SA, a science-based ingredient company, engages in the development of ingredients for food, pet food, animal feed, and dietary supplements using molecular farming technology and precision fermentation platforms in Cayman Islands and internationally. It develops nutritional supplements, food ingredients, meat replacements, and by-products using safflowers, chickpeas, fungi, soybeans… Read more